NCT01708668

Brief Summary

Epidural analgesia is associated with maternal intra-partum fever during labor. Intermittent epidural injections appear to reduce the incidence of maternal intra-partum fever compared to continuous epidural infusion during labor analgesia. However, the optimal combination of bolus volume and administrating interval has not yet been compared. The purpose of this prospective, randomized, double-blind trial was to determine how intermittent epidural bolus reduced the incidence of maternal intra-partum fever compared with continuous epidural infusion during labor.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
12,000

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Oct 2012

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 1, 2012

Completed
6 days until next milestone

First Submitted

Initial submission to the registry

October 7, 2012

Completed
10 days until next milestone

First Posted

Study publicly available on registry

October 17, 2012

Completed
2.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2015

Completed
1.9 years until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2017

Completed
Last Updated

January 15, 2015

Status Verified

January 1, 2015

Enrollment Period

2.7 years

First QC Date

October 7, 2012

Last Update Submit

January 14, 2015

Conditions

Keywords

FeverPatient controlled epidural analgesiaLabor analgesiaEpidural analgesiaCombined spinal-epidural analgesia

Outcome Measures

Primary Outcomes (1)

  • Maternal oral and tympanic temperature

    At time of initiation of analgesia and hourly thereafter until 4 hours postpartum (approximately 12 hours)

Secondary Outcomes (38)

  • Maternal serum Interleukin-1β

    At time of placental delivery and 3, 6 and 12 hours later

  • Cord serum Interleukin-1β

    At time of placental delivery

  • Maternal serum Interleukin-6

    At time of placental delivery and 3, 6 and 12 hours later

  • Cord serum Interleukin-6

    At time of placental delivery

  • Maternal serum Interleukin-10

    At time of placental delivery and 3, 6 and 12 hours later

  • +33 more secondary outcomes

Study Arms (8)

1

ACTIVE COMPARATOR

Epidural analgesia (EA) with continuous epidural infusion(CEI)

Procedure: Epidural analgesiaProcedure: Continuous epidural infusion

2

ACTIVE COMPARATOR

Combined spinal-epidural analgesia (CSEA) with continuous epidural infusion(CEI)

Procedure: Combined spinal-epidural analgesiaProcedure: Continuous epidural infusion

3

ACTIVE COMPARATOR

Epidural analgesia (EA) with intermittent epidural bolus (IEB, 2.5 mL bolused every 15 minutes)

Procedure: Epidural analgesiaProcedure: Intermittent epidural bolus

4

ACTIVE COMPARATOR

Epidural analgesia (EA) with intermittent epidural bolus (IEB, 5ml bolused every 30 minutes)

Procedure: Epidural analgesiaProcedure: Intermittent epidural bolus

5

ACTIVE COMPARATOR

Epidural analgesia (EA) with intermittent epidural bolus (IEB, 10ml bolused every 60 minutes)

Procedure: Epidural analgesiaProcedure: Intermittent epidural bolus

6

ACTIVE COMPARATOR

Combined spinal-epidural analgesia (CSEA) with intermittent epidural bolus (IEB, 2.5 mL bolused every 15 minutes)

Procedure: Combined spinal-epidural analgesiaProcedure: Intermittent epidural bolus

7

ACTIVE COMPARATOR

Combined spinal-epidural analgesia (CSEA) with intermittent epidural bolus (IEB, 5ml bolused every 30 minutes)

Procedure: Combined spinal-epidural analgesiaProcedure: Intermittent epidural bolus

8

ACTIVE COMPARATOR

Combined spinal-epidural analgesia (CSEA) with intermittent epidural bolus (IEB, 10ml bolused every 60 minutes)

Procedure: Combined spinal-epidural analgesiaProcedure: Intermittent epidural bolus

Interventions

Eligibility Criteria

Age20 Years - 45 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Nulliparous women
  • Required labor analgesia
  • Chinese
  • Spontaneous labor

You may not qualify if:

  • Contraindications for epidural analgesia
  • Allergic to opioids and/or local anesthetics
  • Failed to performing epidural catheterization
  • Organic dysfunction
  • Those who were not willing to or could not finish the whole study at any time
  • Using or used in the past 14 days of the monoamine oxidase inhibitors
  • Alcohol addictive or narcotic dependent patients
  • Subjects with a nonvertex presentation or scheduled induction of labor
  • Twin gestation and breech presentation

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Nanjing Maternal and Child Health Care Hospital Affiliated to Nanjing Medical University

Nanjing, Jiangsu, 210004, China

RECRUITING

MeSH Terms

Conditions

Labor PainPainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsFever

Interventions

Analgesia, Epidural

Condition Hierarchy (Ancestors)

Nervous System DiseasesBody Temperature Changes

Intervention Hierarchy (Ancestors)

AnalgesiaAnesthesia and Analgesia

Study Officials

  • Shanwu Feng, M.D.

    Nanjing Medical University

    STUDY DIRECTOR

Central Study Contacts

Shanwu Feng, M.D.

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Department of Anesthesiology, Nanjing Maternal and Child Health Care Hospital, Nanjing, Jiangsu, China, 210004

Study Record Dates

First Submitted

October 7, 2012

First Posted

October 17, 2012

Study Start

October 1, 2012

Primary Completion

July 1, 2015

Study Completion

June 1, 2017

Last Updated

January 15, 2015

Record last verified: 2015-01

Locations